<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="dent" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">dent</book-part-id>
      <title-group>
        <title>Dent Disease</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Lieske</surname>
            <given-names>John C</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Mayo Clinic<break/>Rochester, Minnesota</aff>
          <email>lieske.john@mayo.edu</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Milliner</surname>
            <given-names>Dawn S</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Mayo Clinic<break/>Rochester, Minnesota</aff>
          <email>milliner.dawn@mayo.edu</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Beara-Lasic</surname>
            <given-names>Lada</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>New York University School of Medicine<break/>New York, New York</aff>
          <email>ladabl@yahoo.com</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Harris</surname>
            <given-names>Peter</given-names>
          </name>
          <degrees>PhD</degrees>
          <aff>Mayo Clinic<break/>Rochester, Minnesota</aff>
          <email>harris.peter@mayo.edu</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Hopp</surname>
            <given-names>Katharina</given-names>
          </name>
          <degrees>PhD</degrees>
          <aff>Mayo Clinic<break/>Rochester, Minnesota</aff>
          <email>hopp.katharina@mayo.edu</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Cogal</surname>
            <given-names>Andrea</given-names>
          </name>
          <degrees>BS</degrees>
          <aff>Mayo Clinic<break/>Rochester, Minnesota</aff>
          <email>cogal.andrea@mayo.edu</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Mattison</surname>
            <given-names>Kari</given-names>
          </name>
          <aff>Mayo Clinic<break/>Rochester, Minnesota</aff>
          <email>kamattis@iastate.edu</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>9</day>
          <month>8</month>
          <year>2012</year>
        </date>
        <date date-type="updated">
          <day>25</day>
          <month>9</month>
          <year>2014</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="mpgn" document-type="chapter">Dense Deposit Disease/Membranoproliferative Glomerulonephritis Type II</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="dguok-mtddepl" document-type="chapter">Deoxyguanosine Kinase Deficiency</related-object>
      <abstract id="dent.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Dent disease, an X-linked disorder of proximal renal tubular dysfunction, is characterized by low molecular-weight (LMW) proteinuria, hypercalciuria, nephrocalcinosis, nephrolithiasis, and chronic kidney disease (CKD). Males younger than age ten years may manifest only low molecular-weight (LMW) proteinuria and/or hypercalciuria, which are usually asymptomatic. Thirty to 80% of affected males develop end-stage renal disease (ESRD) between ages 30 and 50 years; in some instances ESRD does not develop until the sixth decade of life or later. Rickets or osteomalacia are occasionally observed, and mild short stature, although underappreciated, may be a common occurrence. Disease severity can vary within the same family. Males with Dent disease 2 (caused by mutation of <italic toggle="yes">OCRL</italic>) are at increased risk for intellectual disability. Due to random X-chromosome inactivation, some female carriers may manifest hypercalciuria and, rarely, renal calculi and moderate LMW proteinuria. Females rarely if ever develop CKD.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis is based on renal findings and/or a family history consistent with X-linked inheritance. A pathogenic variant in <italic toggle="yes">CLCN5</italic> accounts for approximately 60% of those with Dent disease (known as Dent disease 1); a pathogenic variant in <italic toggle="yes">OCRL</italic> accounts for approximately 15% of those with Dent disease (known as Dent disease 2).</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> The primary goals of treatment are to decrease hypercalciuria, prevent kidney stones and nephrocalcinosis, and delay the progression of chronic kidney disease (CKD). No randomized controlled trials have been performed. Although thiazide diuretics can decrease urinary calcium excretion in boys with Dent disease, side effects limit their use. The effectiveness of angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARB) in children with proteinuria to prevent or delay further loss of kidney function is unclear. Renal replacement therapy is necessary in those with ESRD.</p>
          <p><italic toggle="yes">Prevention of secondary complications:</italic> Bone disease, when present, responds to vitamin D supplementation and phosphorus repletion. Growth failure may be treated with human growth hormone without adversely affecting kidney function.</p>
          <p><italic toggle="yes">Surveillance:</italic> Monitor at least annually urinary calcium excretion, renal function (glomerular filtration rate [GFR]), and the parameters used to stage CKD (i.e., blood pressure, hematocrit/hemoglobin, and serum calcium and phosphorous concentrations). Monitor more frequently when CKD is evident.</p>
          <p><italic toggle="yes">Agents/circumstances to avoid:</italic> Exposure to potential renal toxins (nonsteroidal anti-inflammatory drugs, aminoglycoside antibiotics, and intravenous contrast agents).</p>
          <p><italic toggle="yes">Evaluation of relatives at risk:</italic> Clarify the genetic status of at-risk male relatives either by molecular genetic testing (if the pathogenic variant in the family is known) or by measurement of urinary excretion of low molecular-weight proteins (LMWPs).</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>Dent disease is inherited in an X-linked manner. The father of an affected male will not have the disease nor will he be a carrier of the pathogenic variant. If the mother of the proband has a pathogenic variant, the chance of transmitting it in each pregnancy is 50%. Males who inherit the pathogenic variant will be affected; females who inherit the pathogenic variant will be carriers and will usually not be significantly affected. Affected males pass the pathogenic variant to all of their daughters (who become carriers) and none of their sons. Carrier testing for at-risk female relatives and prenatal testing for pregnancies at increased risk are possible if the pathogenic variant in the family has been identified.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="dent.Diagnosis">
        <title>Diagnosis</title>
        <sec id="dent.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p>Diagnosis of Dent disease <bold>should be suspected</bold> in individuals with the three criteria below in the absence of other known causes of proximal tubule dysfunction [<xref ref-type="bibr" rid="dent.REF.hoopes.2004.1615">Hoopes et al 2004</xref>, <xref ref-type="bibr" rid="dent.REF.edvardsson.2013.1923">Edvardsson et al 2013</xref>]. Note: A possible diagnosis of Dent disease is considered if LMW proteinuria and at least one other criterion are present.</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>LMW proteinuria</bold> (the pathognomonic finding of Dent disease) at least five times (and often 10x) above the upper limit of normal. Commonly screened LMW proteins are retinol binding protein and &#x003b1;1 microglobulin.</p>
              <p>Note: &#x003b2;2 microglobulin is also often measured to screen for LMW proteinuria. To the authors&#x02019; knowledge, no known cases of Dent disease have been missed using this screening method; however, its use is cautioned since it is not stable in even minimally acidic urine [<xref ref-type="bibr" rid="dent.REF.davey.1982.1330">Davey &#x00026; Gosling 1982</xref>] and thus could theoretically yield a false negative result.</p>
            </list-item>
            <list-item>
              <p>
                <bold>Hypercalciuria</bold>
              </p>
              <list list-type="bullet">
                <list-item>
                  <p><bold>Adults (age &#x0003e;18 years).</bold> &#x0003e;4.0 mg calcium (0.1 mmol)/kg in 24 hours or &#x0003e;0.25 calcium/creatinine mg/mg (0.57 mmol/mmol) in spot urine</p>
                </list-item>
                <list-item>
                  <p><bold>Children.</bold> See <xref ref-type="table" rid="dent.T.calciumcreatinine_mgmg_reference">Table 1</xref> for 95th percentile calcium/creatinine mg/mg reference values in random urine collections.</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p><bold>At least one</bold> of the following:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Nephrocalcinosis (diffuse renal calcification)</p>
                </list-item>
                <list-item>
                  <p>Nephrolithiasis (kidney stones) (composed of calcium oxalate and/or calcium phosphate)</p>
                </list-item>
                <list-item>
                  <p>Hematuria (microscopic or macroscopic blood in the urine)</p>
                </list-item>
                <list-item>
                  <p>Hypophosphatemia (low blood phosphorous concentration)</p>
                </list-item>
                <list-item>
                  <p>Chronic kidney disease (CKD); measured or estimated glomerular filtration rate (GFR) that is less than the normal limits for age</p>
                </list-item>
                <list-item>
                  <p>Family history consistent with X-linked inheritance</p>
                </list-item>
              </list>
            </list-item>
          </list>
          <p>In 75% of males who meet the above criteria, a pathogenic variant in either <italic toggle="yes">CLCN5</italic> (Dent disease 1) or <italic toggle="yes">OCRL</italic> (Dent disease 2) confirms the diagnosis.</p>
          <table-wrap id="dent.T.calciumcreatinine_mgmg_reference" orientation="portrait" position="anchor">
            <label>Table 1. </label>
            <caption>
              <p>Calcium/Creatinine (mg/mg) Reference Values in Children (age &#x0003c;18 yrs)</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_dent.T.calciumcreatinine_mgmg_reference_1_1_1_1" valign="top" align="left" scope="col" rowspan="1" colspan="1">Age (yr)</th>
                  <th id="hd_h_dent.T.calciumcreatinine_mgmg_reference_1_1_1_2" valign="top" align="left" scope="col" rowspan="1" colspan="1">95th percentile</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_dent.T.calciumcreatinine_mgmg_reference_1_1_1_1" valign="top" align="left" scope="row" rowspan="1" colspan="1">0-1</td>
                  <td headers="hd_h_dent.T.calciumcreatinine_mgmg_reference_1_1_1_2" valign="top" align="left" rowspan="1" colspan="1">&#x0003c;0.81</td>
                </tr>
                <tr>
                  <td headers="hd_h_dent.T.calciumcreatinine_mgmg_reference_1_1_1_1" valign="top" align="left" scope="row" rowspan="1" colspan="1">1-2</td>
                  <td headers="hd_h_dent.T.calciumcreatinine_mgmg_reference_1_1_1_2" valign="top" align="left" rowspan="1" colspan="1">&#x0003c;0.56</td>
                </tr>
                <tr>
                  <td headers="hd_h_dent.T.calciumcreatinine_mgmg_reference_1_1_1_1" valign="top" align="left" scope="row" rowspan="1" colspan="1">2-3</td>
                  <td headers="hd_h_dent.T.calciumcreatinine_mgmg_reference_1_1_1_2" valign="top" align="left" rowspan="1" colspan="1">&#x0003c;0.50</td>
                </tr>
                <tr>
                  <td headers="hd_h_dent.T.calciumcreatinine_mgmg_reference_1_1_1_1" valign="top" align="left" scope="row" rowspan="1" colspan="1">3-5</td>
                  <td headers="hd_h_dent.T.calciumcreatinine_mgmg_reference_1_1_1_2" valign="top" align="left" rowspan="1" colspan="1">&#x0003c;0.41</td>
                </tr>
                <tr>
                  <td headers="hd_h_dent.T.calciumcreatinine_mgmg_reference_1_1_1_1" valign="top" align="left" scope="row" rowspan="1" colspan="1">5-7</td>
                  <td headers="hd_h_dent.T.calciumcreatinine_mgmg_reference_1_1_1_2" valign="top" align="left" rowspan="1" colspan="1">&#x0003c;0.30</td>
                </tr>
                <tr>
                  <td headers="hd_h_dent.T.calciumcreatinine_mgmg_reference_1_1_1_1" valign="top" align="left" scope="row" rowspan="1" colspan="1">7-10</td>
                  <td headers="hd_h_dent.T.calciumcreatinine_mgmg_reference_1_1_1_2" valign="top" align="left" rowspan="1" colspan="1">&#x0003c;0.25</td>
                </tr>
                <tr>
                  <td headers="hd_h_dent.T.calciumcreatinine_mgmg_reference_1_1_1_1" valign="top" align="left" scope="row" rowspan="1" colspan="1">10-14</td>
                  <td headers="hd_h_dent.T.calciumcreatinine_mgmg_reference_1_1_1_2" valign="top" align="left" rowspan="1" colspan="1">&#x0003c;0.24</td>
                </tr>
                <tr>
                  <td headers="hd_h_dent.T.calciumcreatinine_mgmg_reference_1_1_1_1" valign="top" align="left" scope="row" rowspan="1" colspan="1">14-17</td>
                  <td headers="hd_h_dent.T.calciumcreatinine_mgmg_reference_1_1_1_2" valign="top" align="left" rowspan="1" colspan="1">&#x0003c;0.24</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>In random urine collections</p>
              </fn>
              <fn>
                <p>
                  <xref ref-type="bibr" rid="dent.REF.matos.1997.252">Matos et al [1997]</xref>
                </p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p><bold>Renal biopsy.</bold> Findings consistent with Dent disease include nephrocalcinosis, interstitial fibrosis, and focal segmental glomerulosclerosis (FSGS) and/or focal global glomerulosclerosis (FGGS) [<xref ref-type="bibr" rid="dent.REF.copelovitch.2007.914">Copelovitch et al 2007</xref>, <xref ref-type="bibr" rid="dent.REF.frishberg.2009.2369">Frishberg et al 2009</xref>].</p>
        </sec>
        <sec id="dent.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>The diagnosis of Dent disease <bold>is established</bold> in a proband with the identification of a pathogenic variant in either <italic toggle="yes">CLCN5</italic> or <italic toggle="yes">OCRL</italic> (see <xref ref-type="table" rid="dent.T.summary_of_molecular_genetic_test">Table 2</xref>).</p>
          <p><bold>One genetic testing strategy</bold> is molecular genetic testing of <italic toggle="yes">CLCN5</italic> (Dent disease 1) or <italic toggle="yes">OCRL</italic> (Dent disease 2).</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>For males or females.</bold> Sequence analysis of <italic toggle="yes">CLCN5</italic> is performed first; if a pathogenic variant is not identified, perform sequence analysis of <italic toggle="yes">OCRL</italic>.</p>
              <p>Note: Sequence analysis of affected males provides putative identification of (multi)exon and whole-gene deletions due to lack of amplification; confirmation may require deletion/duplication analysis.</p>
            </list-item>
            <list-item>
              <p><bold>In a female.</bold> If a pathogenic variant is not detected in either gene by sequence analysis, consider deletion/duplication analysis of <italic toggle="yes">CLCN5</italic>, followed by <italic toggle="yes">OCRL</italic>.</p>
            </list-item>
          </list>
          <p><bold>An alternative genetic testing strategy</bold> is use of a multi-gene panel that includes <italic toggle="yes">CLCN5, OCRL</italic>, and other genes of interest (see <xref ref-type="sec" rid="dent.Differential_Diagnosis">Differential Diagnosis</xref>). Note: The genes included and the methods used in multi-gene panels vary by laboratory and over time.</p>
          <table-wrap id="dent.T.summary_of_molecular_genetic_test" orientation="portrait" position="anchor">
            <label>Table 2. </label>
            <caption>
              <p>Summary of Molecular Genetic Testing Used in Dent Disease</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_dent.T.summary_of_molecular_genetic_test_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup><break/>(Phenotype)</th>
                  <th id="hd_h_dent.T.summary_of_molecular_genetic_test_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Proportion of Dent Disease Attributed to Mutation of This Gene&#x000a0;<sup>2</sup></th>
                  <th id="hd_h_dent.T.summary_of_molecular_genetic_test_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_dent.T.summary_of_molecular_genetic_test_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1"><italic toggle="yes">CLCN5</italic><break/>(Dent disease1)</td>
                  <td headers="hd_h_dent.T.summary_of_molecular_genetic_test_1_1_1_2" rowspan="2" valign="middle" align="left" colspan="1">60%</td>
                  <td headers="hd_h_dent.T.summary_of_molecular_genetic_test_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>3,&#x000a0;4,&#x000a0;5,&#x000a0;6</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_dent.T.summary_of_molecular_genetic_test_1_1_1_3" valign="middle" colspan="1" align="left" scope="col" rowspan="1">Deletion/duplication analysis&#x000a0;<sup>6,&#x000a0;7</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_dent.T.summary_of_molecular_genetic_test_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1"><italic toggle="yes">OCRL</italic><break/>(Dent disease 2)</td>
                  <td headers="hd_h_dent.T.summary_of_molecular_genetic_test_1_1_1_2" rowspan="2" valign="middle" align="left" colspan="1">15%</td>
                  <td headers="hd_h_dent.T.summary_of_molecular_genetic_test_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>3,&#x000a0;4,&#x000a0;5,&#x000a0;8</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_dent.T.summary_of_molecular_genetic_test_1_1_1_3" valign="middle" colspan="1" align="left" scope="col" rowspan="1">Deletion/duplication analysis&#x000a0;<sup>7,&#x000a0;8</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_dent.T.summary_of_molecular_genetic_test_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Unknown&#x000a0;<sup>9</sup></td>
                  <td headers="hd_h_dent.T.summary_of_molecular_genetic_test_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_dent.T.summary_of_molecular_genetic_test_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">NA</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="dent.TF.2.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="dent" object-id="dent.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein. See <xref ref-type="sec" rid="dent.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
              </fn>
              <fn id="dent.TF.2.2">
                <label>2. </label>
                <p>
                  <xref ref-type="bibr" rid="dent.REF.claveriemart_n.2011.693">Claverie-Mart&#x000ed;n et al [2011]</xref>
                </p>
              </fn>
              <fn id="dent.TF.2.3">
                <label>3. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="dent.TF.2.4">
                <label>4. </label>
                <p>Lack of amplification by PCR prior to sequence analysis can suggest a putative (multi)exon or whole-gene deletion on the X chromosome in affected males; confirmation may require additional testing by deletion/duplication analysis.</p>
              </fn>
              <fn id="dent.TF.2.5">
                <label>5. </label>
                <p>Sequence analysis of genomic DNA cannot detect deletion of one or more exons or the entire X-linked gene in a heterozygous female.</p>
              </fn>
              <fn id="dent.TF.2.6">
                <label>6. </label>
                <p>Of the 174 different <italic toggle="yes">CLCN5</italic> pathogenic variants known to cause Dent disease 1 identified to date, ~5% are complex rearrangements (large deletions, insertions, or indels).</p>
              </fn>
              <fn id="dent.TF.2.7">
                <label>7. </label>
                <p>Testing that identifies exon or whole-gene deletions/duplications not detectable by sequence analysis of the coding and flanking intronic regions of genomic DNA. Included in the variety of methods that may be used are: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and chromosomal microarray (CMA) that includes this gene/chromosome segment.</p>
              </fn>
              <fn id="dent.TF.2.8">
                <label>8. </label>
                <p>Of the 40 different <italic toggle="yes">OCRL</italic> pathogenic variants known to cause Dent disease 2 identified to date, 5% are multiexon deletions.</p>
              </fn>
              <fn id="dent.TF.2.9">
                <label>9. </label>
                <p>Approximately 25% of those with Dent disease do not have an identified pathogenic variant in <italic toggle="yes">CLCN5</italic> or <italic toggle="yes">OCRL</italic>, suggesting additional genetic heterogeneity [<xref ref-type="bibr" rid="dent.REF.hoopes.2004.1615">Hoopes et al 2004</xref>, <xref ref-type="bibr" rid="dent.REF.hoopes.2005.260">Hoopes et al 2005</xref>].</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p><bold>Test characteristics.</bold> See <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.eurogentest.org/index.php?id=668">Clinical Utility Gene Card</ext-link> [<xref ref-type="bibr" rid="dent.REF.ludwig.2014">Ludwig et al 2014</xref>] for information on test characteristics including sensitivity and specificity.</p>
        </sec>
      </sec>
      <sec id="dent.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="dent.Clinical_Description">
          <title>Clinical Description</title>
          <p>In the early stages of Dent disease, children (typically &#x0003c;~10 years) may manifest only low molecular-weight (LMW) proteinuria and/or hypercalciuria, both of which are usually asymptomatic [<xref ref-type="bibr" rid="dent.REF.claveriemart_n.2011.693">Claverie-Mart&#x000ed;n et al 2011</xref>].</p>
          <p>LMW proteinuria and/or hypercalciuria can be accompanied by stone disease or nephrocalcinosis, and less frequently by other manifestations of proximal tubular dysfunction including aminoaciduria, phosphaturia, and glycosuria [<xref ref-type="bibr" rid="dent.REF.hodgin.2008.1320">Hodgin et al 2008</xref>]. The disease may also be accompanied by rickets or osteomalacia, short stature, and growth retardation [<xref ref-type="bibr" rid="dent.REF.b_kenkamp.2009.94">B&#x000f6;kenkamp et al 2009</xref>]. Hypercalciuria is typically accompanied by elevated or high-normal levels of 1,25-dihydroxyvitamin D, and depressed or low-normal levels of intact PTH [<xref ref-type="bibr" rid="dent.REF.scheinman.1998.3">Scheinman 1998</xref>]. Hypercalciuria largely or completely resolves with dietary calcium restriction, suggesting that the major component of hypercalciuria is intestinal hyperabsorption.</p>
          <p>An estimated 30%-80% of affected males develop end-stage renal disease (ESRD) between ages 30 and 50 years; in some instances ESRD does not develop until the sixth decade or later [<xref ref-type="bibr" rid="dent.REF.wrong.1994.473">Wrong et al 1994</xref>, <xref ref-type="bibr" rid="dent.REF.lloyd.1997.967">Lloyd et al 1997</xref>]. Of note, deterioration of renal function can occur even in the absence of nephrocalcinosis. Disease severity can vary even within the same family.</p>
          <p>Short stature is common, although not usually profound in Dent disease 1. In one series height was -0.58 SD of the age-appropriate mean value for Dent disease 1 and -2.10 SD for Dent disease 2 [<xref ref-type="bibr" rid="dent.REF.b_kenkamp.2009.94">B&#x000f6;kenkamp et al 2009</xref>].</p>
          <sec id="dent.Dent_Disease_1_caused_by_mutation_o">
            <title>Dent Disease 1 (caused by mutation of <italic toggle="yes">CLCN5</italic>)</title>
            <p>The phenotypic findings in Dent 1 vary.</p>
            <p><xref ref-type="bibr" rid="dent.REF.scheinman.2000.232">Scheinman et al [2000]</xref> reported a family in which all affected individuals had the same <italic toggle="yes">CLCN5</italic> missense variant (c.1517G&#x0003e;A; p.Gly506Glu) and the Dent disease phenotype ranged from severe in several members to isolated hypercalciuria without proteinuria, nephrocalcinosis, or chronic kidney disease (CKD) in one. It is not currently known how often an individual with a <italic toggle="yes">CLCN5</italic> pathogenic variant manifests only asymptomatic hypercalciuria and/or proteinuria without developing CKD.</p>
            <p>Some individuals with a pathogenic variant in <italic toggle="yes">CLCN5</italic> and a family history of Dent disease developed ESRD with proteinuria, but without other typical features of Dent disease (i.e., kidney stones, nephrocalcinosis, and bone disease) [<xref ref-type="bibr" rid="dent.REF.copelovitch.2007.914">Copelovitch et al 2007</xref>, <xref ref-type="bibr" rid="dent.REF.frishberg.2009.2369">Frishberg et al 2009</xref>]. Renal biopsy revealed focal segmental glomerulosclerosis (FSGS) and focal global glomerulosclerosis. The findings in these individuals illustrate that the spectrum of Dent disease includes persons with proteinuria and a biopsy consistent with FSGS and that the diagnosis is only considered when evaluations for LMW proteinuria and/or hypercalciuria are performed.</p>
            <p>It is currently unclear if Dent disease will be diagnosed among a larger number of individuals with clinical FSGS.</p>
          </sec>
          <sec id="dent.Dent_Disease_2_caused_by_mutation_o">
            <title>Dent Disease 2 (caused by mutation of <italic toggle="yes">OCRL</italic>)</title>
            <p>To date, about 25 males with Dent disease 2 have been reported.</p>
            <p>The males in the initial report of Dent disease 2 exhibited none of the classic extrarenal symptoms of <related-object link-type="booklink" source-id="gene" document-id="lowe" document-type="chapter">Lowe syndrome</related-object>, an allelic disorder, which is characterized by congenital cataracts, hypotonia and delayed motor milestones, intellectual disability, and renal tubular involvement that leads to bone disease and growth retardation [<xref ref-type="bibr" rid="dent.REF.hoopes.2005.260">Hoopes et al 2005</xref>]. Although males with classic Lowe syndrome have a renal phenotype similar to that of Dent disease, the tubular dysfunction is somewhat different:</p>
            <list list-type="bullet">
              <list-item>
                <p>Tubular acidosis, one of the cardinal signs of Lowe syndrome, is rare in Dent disease.</p>
              </list-item>
              <list-item>
                <p>Features of Fanconi syndrome (amino aciduria, glucosuria, renal tubular acidosis) are observed more frequently in Lowe syndrome than in Dent disease.</p>
              </list-item>
              <list-item>
                <p>Hypercalciuria, nephrocalcinosis, and nephrolithiasis are common in Dent disease but rare in Lowe syndrome.</p>
              </list-item>
            </list>
            <p>Given the finding of <italic toggle="yes">OCRL</italic> pathogenic variants in about 15% of individuals with Dent disease, it has been suggested that pathogenic variants in <italic toggle="yes">OCRL</italic> are associated with a phenotypic continuum along a spectrum that ranges from Lowe syndrome at the severe end (see <xref ref-type="sec" rid="dent.Genetically_Related_Allelic_Disorde">Genetically Related Disorders</xref>) to Dent disease 2 at the mild end.</p>
            <p>An estimated 6/11 males with an <italic toggle="yes">OCRL</italic> pathogenic variant and a Dent phenotype have mild intellectual disability, whereas cataracts are rare and renal tubular acidosis has not generally been observed [<xref ref-type="bibr" rid="dent.REF.hoopes.2005.260">Hoopes et al 2005</xref>, <xref ref-type="bibr" rid="dent.REF.shrimpton.2009.27">Shrimpton et al 2009</xref>].</p>
            <list list-type="bullet">
              <list-item>
                <p>Males with <italic toggle="yes">OCRL</italic> pathogenic variants who have typical findings of Dent disease (low molecular-weight proteinuria, hypercalciuria, amino aciduria) have been observed to have mild intellectual disability [<xref ref-type="bibr" rid="dent.REF.hoopes.2005.260">Hoopes et al 2005</xref>, <xref ref-type="bibr" rid="dent.REF.lozanovski.2011.280">Lozanovski et al 2011</xref>, <xref ref-type="bibr" rid="dent.REF.tasic.2011.557">Tasic et al 2011</xref>]. Unlike the renal disease in Lowe syndrome, the proximal tubular dysfunction and renal tubular acidosis observed in these individuals are not severe enough to require bicarbonate therapy [<xref ref-type="bibr" rid="dent.REF.hoopes.2005.260">Hoopes et al 2005</xref>].</p>
              </list-item>
              <list-item>
                <p>Within one family reported, some affected individuals had mild intellectual disability while others did not [<xref ref-type="bibr" rid="dent.REF.hoopes.2005.260">Hoopes et al 2005</xref>].</p>
              </list-item>
              <list-item>
                <p>In a cohort from Germany, elevated muscle enzymes (LDH, CPK) were observed in about half of males with an <italic toggle="yes">OCRL</italic> pathogenic variant and a Dent phenotype, while intellectual disability was observed in only one of 21 affected males [<xref ref-type="bibr" rid="dent.REF.utsch.2006.942.e1">Utsch et al 2006</xref>].</p>
              </list-item>
              <list-item>
                <p>In a cohort from Korea, two of 12 males with a Dent phenotype had an <italic toggle="yes">OCRL</italic> pathogenic variant; one of these had mild developmental delay and elevated muscle enzymes, while the other did not. All seven males with the Lowe syndrome phenotype had an <italic toggle="yes">OCRL</italic> pathogenic variant. Urine B2 microglobulin excretion was increased in males with an <italic toggle="yes">OCRL</italic> pathogenic variant (Dent disease or Lowe syndrome phenotype), while renal tubular acidosis was present in all males with Lowe syndrome, but not in males with Dent disease caused by either a <italic toggle="yes">CLCN5</italic> or an <italic toggle="yes">OCRL</italic> pathogenic variant [<xref ref-type="bibr" rid="dent.REF.cho.2008.243">Cho et al 2008</xref>].</p>
              </list-item>
            </list>
          </sec>
          <sec id="dent.Symptomatic_Females">
            <title>Symptomatic Females</title>
            <p>There have been occasional reports of renal calculi and moderate LMW proteinuria when carrier females have been studied in large kindreds. Rarely, heterozygous females manifest clinically significant kidney disease resulting from skewed X-chromosome inactivation. One female from a family with Dent disease developed renal insufficiency and nephrocalcinosis; however, she did not have genetic testing [<xref ref-type="bibr" rid="dent.REF.wrong.1994.473">Wrong et al 1994</xref>].</p>
            <p>Although not reported in the literature, a symptomatic female could have an X-chromosome abnormality (e.g., absence of one X chromosome [45,X] and a <italic toggle="yes">CLCN5</italic> or <italic toggle="yes">OCRL</italic> pathogenic variant on the remaining X chromosome).</p>
            <p>Although not reported in the literature, a female with biallelic pathogenic variants in <italic toggle="yes">CLCN5</italic> or <italic toggle="yes">OCRL</italic> (inherited from a carrier mother and an affected father) would be predicted to manifest clinically significant kidney disease.</p>
          </sec>
        </sec>
        <sec id="dent.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p><bold><italic toggle="yes">CLCN5</italic></bold>. Genotype-phenotype correlations have yet to be established.</p>
          <p><bold><italic toggle="yes">OCRL</italic></bold><italic toggle="yes">.</italic> It has been suggested that mutation of <italic toggle="yes">OCRL</italic> is associated with a phenotypic continuum along a spectrum that ranges from Lowe syndrome at the severe end (see <xref ref-type="sec" rid="dent.Genetically_Related_Allelic_Disorde">Genetically Related Disorders</xref>) to Dent disease 2 at the mild end (see <xref ref-type="sec" rid="dent.Clinical_Characteristics">Clinical Characteristics</xref>).</p>
          <p>Note: Although the renal tubulopathy in Lowe syndrome (which is mainly characterized by altered protein reabsorption) and Dent disease is similar, it is generally milder in Dent disease. Of note, this milder Dent disease phenotype could not be attributed to lesser protein expression or enzyme activity.</p>
          <p>Frameshift and nonsense <italic toggle="yes">OCRL</italic> variants associated with Dent disease 2 have been mapped to exons different from those causing Lowe syndrome [<xref ref-type="bibr" rid="dent.REF.hichri.2011.379">Hichri et al 2011</xref>]; however, <italic toggle="yes">OCRL</italic> missense and splicing variants and in-frame deletions that cause these two disorders do not map exclusively to specific gene regions.</p>
          <list list-type="bullet">
            <list-item>
              <p>Frameshift and nonsense variants associated with Dent disease 2 are in the first seven exons. Missense variants associated with Dent disease 2 are most often, but not exclusively, located in exons 9-15, which encode the catalytic phosphatase domain.</p>
            </list-item>
            <list-item>
              <p>Frameshift and nonsense variants associated with Lowe syndrome are located in the middle and later regions of the gene, exons 8-23, which encode the catalytic phosphatase and the Rho-GAP-like domain [<xref ref-type="bibr" rid="dent.REF.tosetto.2009.1967">Tosetto et al 2009</xref>, <xref ref-type="bibr" rid="dent.REF.hichri.2011.379">Hichri et al 2011</xref>].</p>
            </list-item>
          </list>
        </sec>
        <sec id="dent.Prevalence">
          <title>Prevalence</title>
          <p>To date about 250 affected families have been reported [<xref ref-type="bibr" rid="dent.REF.devuyst.2010.28">Devuyst &#x00026; Thakker 2010</xref>]. However, the wide variability of clinical presentation in Dent disease and (in some cases) absence of family history make diagnosis difficult; thus, the disorder is likely underdiagnosed.</p>
        </sec>
      </sec>
      <sec id="dent.Genetically_Related_Allelic_Disorde">
        <title>Genetically Related (Allelic) Disorders</title>
        <p><bold><italic toggle="yes">CLCN5.</italic></bold> No other phenotypes are known to be associated with mutation of <italic toggle="yes">CLCN5.</italic></p>
        <p><bold><italic toggle="yes">OCRL</italic>.</bold> Mutation of <italic toggle="yes">OCRL</italic> is known to cause <related-object link-type="booklink" source-id="gene" document-id="lowe" document-type="chapter">Lowe syndrome</related-object> (oculocerebrorenal syndrome), characterized by involvement of the eyes, central nervous system, and kidneys. Dense congenital cataracts are found in all affected boys and infantile glaucoma in approximately 50%. Generalized central hypotonia noted at birth may slowly improve with age, but normal motor tone and strength are never achieved and motor milestones are delayed. Almost all affected males have some degree of intellectual disability (ID): 10%-25% function in the low-normal or borderline range, approximately 25% in the mild-to-moderate range of ID, and 50%-65% in the severe-to-profound range of ID. Affected males have profound short stature and varying degrees of proximal renal tubular dysfunction of the Fanconi type, including bicarbonate wasting and renal tubular acidosis, phosphaturia with hypophosphatemia, renal rickets, aminoaciduria, LMW proteinuria, sodium and potassium wasting, and polyuria. Fanconi syndrome is usually not clinically apparent in the first few months of life, but symptoms may appear by age six to 12 months. Glomerulosclerosis associated with chronic tubular injury usually results in slowly progressive chronic renal failure and end-stage renal disease (ESRD) after age ten to 20 years. Molecular genetic testing of <italic toggle="yes">OCRL</italic> detects pathogenic variants in approximately 95% of affected males and carrier females.</p>
        <p>Given the finding of <italic toggle="yes">OCRL</italic> pathogenic variants in about 15% of individuals with Dent disease, it has been suggested that mutation of <italic toggle="yes">OCRL</italic> is associated with a phenotypic continuum along a spectrum that ranges from Lowe syndrome at the severe end to Dent disease 2 at the mild end. See <xref ref-type="sec" rid="dent.Clinical_Characteristics">Clinical Characteristics</xref>.</p>
      </sec>
      <sec id="dent.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Low molecular-weight (LMW) proteinuria is a prominent and characteristic feature of Dent disease and, therefore, the differential diagnosis of Dent disease includes other causes of proximal tubular dysfunction.</p>
        <p>The presence of a more generalized proximal tubular dysfunction (glucosuria, amino aciduria, renal tubular acidosis) would suggest the possibility of a Fanconi syndrome. Causes of Fanconi syndromes can be hereditary (e.g., <related-object link-type="booklink" source-id="gene" document-id="wilson" document-type="chapter">Wilson disease</related-object>, glycogen storage disease) or acquired (e.g., exposure to heavy metal, toluene, or cisplatin).</p>
        <p>Some individuals with Dent disease 1 with more severe proteinuria were found to have FSGS or global sclerosis on kidney biopsy [<xref ref-type="bibr" rid="dent.REF.copelovitch.2007.914">Copelovitch et al 2007</xref>, <xref ref-type="bibr" rid="dent.REF.frishberg.2009.2369">Frishberg et al 2009</xref>]. Therefore, Dent disease needs to be considered in persons with FSGS or asymptomatic proteinuria, since immunosuppressive therapies would not be effective and are potentially harmful in these individuals [<xref ref-type="bibr" rid="dent.REF.valina.2013.377">Valina et al 2013</xref>].</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="donnai" document-type="chapter"><bold>Donnai-Barrow syndrome</bold></related-object><bold>,</bold> caused by mutation of <italic toggle="yes">LRP2</italic> which encodes megalin, a 600-kd multiligand endocytic receptor, bears some similarities to Dent disease [<xref ref-type="bibr" rid="dent.REF.kantarci.2007.957">Kantarci et al 2007</xref>]. Clinical manifestations of this rare disorder include hypertelorism, large anterior fontanelle, agenesis of the corpus callosum and congenital diaphragmatic hernia [<xref ref-type="bibr" rid="dent.REF.pober.2009.76">Pober et al 2009</xref>]. Low molecular-weight proteinuria and high myopia, have been consistently observed in these patients [<xref ref-type="bibr" rid="dent.REF.pober.2009.76">Pober et al 2009</xref>]. However, other typical findings of Dent disease, including nephrolithiasis, nephrocalcinosis, hypercalciuria, chronic kidney disease, or bone disease have not been reported to date.</p>
      </sec>
      <sec id="dent.Management">
        <title>Management</title>
        <sec id="dent.Evaluations_Following_Initial_Diagn">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs of an individual diagnosed with Dent disease, the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Assessment of renal function (measured or estimated GFR; urine protein excretion)</p>
            </list-item>
            <list-item>
              <p>Assessment for nephrocalcinosis and kidney stones by imaging studies</p>
              <p>For those with evidence of renal stones or nephrocalcinosis: urine studies for kidney stone risk factors (including calcium and citrate excretion)</p>
            </list-item>
            <list-item>
              <p>Assessment of risk for bone disease (serum calcium, phosphorus, and alkaline phosphatase)</p>
              <p>Note: Elevated alkaline phosphatase has been reported in all individuals with clinical rickets [<xref ref-type="bibr" rid="dent.REF.wrong.1994.473">Wrong et al 1994</xref>].</p>
              <p>For those with evidence of bone disease and/or growth delay: more complete assessment of bone health (i.e., serum vitamin D concentration and parathyroid hormone [PTH] level; x-rays of long bones for evidence of osteomalacia)</p>
            </list-item>
            <list-item>
              <p>In children, evaluation of stature using standard growth charts</p>
            </list-item>
            <list-item>
              <p>Clinical genetics consultation</p>
            </list-item>
          </list>
        </sec>
        <sec id="dent.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>No guidelines have been established for treatment of Dent disease. The primary goals of treatment are to decrease hypercalciuria, prevent kidney stones and nephrocalcinosis, and delay the progression of chronic kidney disease (CKD).</p>
          <p>Interventions aimed at decreasing hypercalciuria and preventing kidney stones and nephrocalcinosis have not been tested in randomized controlled trials. Thiazide diuretics in doses greater than 0.4 mg/kg/day have decreased urinary calcium excretion by more than 40% in boys with Dent disease [<xref ref-type="bibr" rid="dent.REF.raja.2002.2938">Raja et al 2002</xref>, <xref ref-type="bibr" rid="dent.REF.blanchard.2008.1084">Blanchard et al 2008</xref>]. However, frequent side effects included hypokalemia, volume depletion, and cramping. Careful dosing and close monitoring for these side effects are necessary.</p>
          <p>Angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARB) have been used in children with proteinuria to prevent or delay further loss of kidney function; however, their effectiveness has not been clear. Note: Treatment with ACE inhibitors or ARB may be somewhat beneficial, at least in those with focal segmental glomerulosclerosis (FSGS) on kidney biopsy, as angiotensin blockade is not thought to significantly affect LMW proteinuria.</p>
          <p>Although a high citrate diet has been shown to slow progression of CKD in clcn5 knockout mice [<xref ref-type="bibr" rid="dent.REF.cebotaru.2005.642">Cebotaru et al 2005</xref>] and has been used in the treatment of Dent disease, no human trials have proven its effectiveness. Note: Citrate is commonly used in <related-object link-type="booklink" source-id="gene" document-id="lowe" document-type="chapter">Lowe syndrome</related-object> to treat the metabolic acidosis resulting from renal tubular acidosis.</p>
          <p>If males with Dent disease progress to ESRD, renal replacement therapy becomes necessary. Hemodialysis, peritoneal dialysis, and renal transplantation are appropriate options. Because Dent disease manifestations are largely localized in the kidney, the disease will not recur.</p>
        </sec>
        <sec id="dent.Prevention_of_Secondary_Complicatio">
          <title>Prevention of Secondary Complications</title>
          <p>Bone disease has not been a prominent component of Dent disease in recent case series. When present it has been reported to respond to vitamin D supplementation and phosphorus repletion in those with elevated serum alkaline phosphatase levels [<xref ref-type="bibr" rid="dent.REF.wrong.1994.473">Wrong et al 1994</xref>].</p>
          <p>Limited reports suggest that growth failure can be successfully treated with human growth hormone without adversely affecting kidney function [<xref ref-type="bibr" rid="dent.REF.shefferbabila.2008.279">Sheffer-Babila et al 2008</xref>].</p>
        </sec>
        <sec id="dent.Surveillance">
          <title>Surveillance</title>
          <p>Renal function measured as glomerular filtration rate (GFR) should be monitored at least annually together with the parameters used to stage chronic kidney disease (i.e., blood pressure, hematocrit/hemoglobin, urinary calcium excretion, and serum calcium and phosphorus concentrations).</p>
          <p>More frequent visits and monitoring for complications of chronic kidney disease (i.e., hypertension, anemia, and secondary hyperparathyroidism) as well as consideration of intensified treatment of cardiovascular risk factors may be indicated if GFR falls below 45 mL/min/1.73 m<sup>2</sup> (CKD Stage 3B).</p>
        </sec>
        <sec id="dent.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>Exposure to potential renal toxins (nonsteroidal anti-inflammatory drugs, aminoglycoside antibiotics, and intravenous contrast agents) should be avoided, especially if renal function is below 45 mL/min/1.73 m<sup>2</sup> (CKD stage 3B).</p>
        </sec>
        <sec id="dent.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>It is appropriate to evaluate male relatives at risk for Dent disease 1 (caused by mutation of <italic toggle="yes">CLCN5</italic>) or Dent disease 2 (caused by mutation of <italic toggle="yes">OCRL</italic>) in order to identify as early as possible those who would benefit from initiation of treatment and preventive measures.</p>
          <list list-type="bullet">
            <list-item>
              <p>If the pathogenic variant in the family is known, molecular genetic testing can be used to clarify the genetic status of at-risk relatives.</p>
            </list-item>
            <list-item>
              <p>If the pathogenic variant in the family is not known, measurement of urinary excretion of low molecular-weight proteins (e.g., alpha 1 microglobulin, retinol binding protein) is a sensitive and specific test.</p>
            </list-item>
          </list>
          <p>See <xref ref-type="sec" rid="dent.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="dent.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov">Clinical Trials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
      </sec>
      <sec id="dent.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="dent.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Dent disease is inherited in an X-linked manner.</p>
        </sec>
        <sec id="dent.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The father of an affected male will not have the disease nor will he be a carrier of a <italic toggle="yes">CLCN5</italic> or <italic toggle="yes">OCRL</italic> pathogenic variant.</p>
            </list-item>
            <list-item>
              <p>In a family with more than one affected individual, the mother of an affected male is an obligate carrier. Note: If a woman has more than one affected child and no other affected relatives and if the pathogenic variant cannot be detected in her leukocyte DNA, she has germline mosaicism.</p>
            </list-item>
            <list-item>
              <p>If a male is the only affected family member (i.e., a simplex case), the mother may be a carrier or the affected male may have a <italic toggle="yes">de novo</italic> pathogenic variant and, thus, the mother is not a carrier. The frequency of <italic toggle="yes">de novo</italic> pathogenic variants is not known.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to sibs depends on the carrier status of the mother.</p>
            </list-item>
            <list-item>
              <p>If the mother of the proband has a <italic toggle="yes">CLCN5</italic> or <italic toggle="yes">OCRL</italic> pathogenic variant, the chance of transmitting it in each pregnancy is 50%. Males who inherit the pathogenic variant will be affected; females who inherit the pathogenic variant will be carriers and will usually not be significantly affected. However, due to the possibility of skewed X-chromosome inactivation, some female carriers may manifest clinically significant kidney disease.</p>
            </list-item>
            <list-item>
              <p>If the proband represents a simplex case (i.e., a single occurrence in a family) and if the pathogenic variant cannot be detected in the leukocyte DNA of the mother, the risk to sibs is low but greater than that of the general population because of the possibility of maternal germline mosaicism.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a male proband.</bold> Affected males pass the pathogenic variant to all of their daughters (who become carriers) and none of their sons.</p>
          <p><bold>Other family members.</bold> The proband's maternal aunts may be at risk of being carriers and the aunts&#x02019; offspring, depending on their gender, may be at risk of being carriers or of being affected.</p>
          <p>Note: Molecular genetic testing may be able to identify the family member in whom a <italic toggle="yes">de novo</italic> pathogenic variant arose, information that could help determine genetic risk status of the extended family.</p>
        </sec>
        <sec id="dent.Carrier_Detection">
          <title>Carrier Detection</title>
          <p><bold>Molecular genetic testing.</bold> Carrier testing for at-risk female relatives is possible if the <italic toggle="yes">CLCN5</italic> or <italic toggle="yes">OCRL</italic> pathogenic variant in the family has been identified.</p>
          <p>LMW proteins are often found to be elevated in female carriers; however, the sensitivity and specificity of such testing for carrier detection have not been established.</p>
        </sec>
        <sec id="dent.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p>See <xref ref-type="sec" rid="dent.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</xref> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of carrier status, and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected, are carriers, or are at risk of being carriers.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="dent.Prenatal_Testing_and_Preimplantatio">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the <italic toggle="yes">CLCN5</italic> or <italic toggle="yes">OCRL</italic> pathogenic variant has been identified in an affected family member, prenatal testing for a pregnancy at increased risk and preimplantation genetic diagnosis for Dent disease are possible.</p>
          <p>Requests for prenatal testing for conditions which (like Dent disease) have some treatment available are not common. Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. Although decisions about prenatal testing are the choice of the parents, discussion of these issues is appropriate.</p>
        </sec>
      </sec>
      <sec id="dent.Resources">
        <title>Resources</title>
      </sec>
      <sec id="dent.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <p>
          <bold>
            <italic toggle="yes">CLCN5</italic>
          </bold>
        </p>
        <p><bold>Gene structure.</bold> The <italic toggle="yes">CLCN5</italic> reference sequence <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_000084.2">NM_000084.2</ext-link> has 12 exons. Alternatively spliced transcript variants encoding different isoforms have been found for this gene (see <related-object source-id="gene" document-id="dent" object-id="dent.molgen.TA">Table A</related-object>, <bold>Gene</bold>). The genomic reference sequence is <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NG_007159.2">NG_007159.2</ext-link>.</p>
        <p><bold>Pathogenic variants.</bold> To date 174 different <italic toggle="yes">CLCN5</italic> pathogenic variants known to cause Dent disease type 1. The majority of these are private: ~74% of all pathogenic variants have been found in only one family, common variants, found in &#x02265;4 families, are summarized in <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="dent-Tables4-5.pdf" content-type="local-data">Table 4</inline-supplementary-material> (pdf). Approximately 52% are truncating, ~42% non-truncating, and ~5% complex rearrangements (large deletions, insertions or indels).</p>
        <p>More than 100 different nonsense or missense variants, insertions or deletions, and splicing variants in <italic toggle="yes">CLCN5</italic> have been reported [<xref ref-type="bibr" rid="dent.REF.devuyst.2010.28">Devuyst &#x00026; Thakker 2010</xref>, <xref ref-type="bibr" rid="dent.REF.claveriemart_n.2011.693">Claverie-Mart&#x000ed;n et al 2011</xref>], meaning that the spectrum of <italic toggle="yes">CLCN5</italic> pathogenic variants is highly varied and <italic toggle="yes">de novo</italic> pathogenic variants are frequent.</p>
        <p><italic toggle="yes">CLCN5</italic> pathogenic variants are scattered throughout the coding sequence of the gene and generate truncated or absent clC-5 channels in approximately 70% of cases.</p>
        <p>Most <italic toggle="yes">CLCN5</italic> pathogenic variants have not yet been fully investigated functionally. Nine that were functionally investigated [<xref ref-type="table" rid="dent.T.clcn5_pathogenic_variants_discuss">Table 3</xref>, <xref ref-type="bibr" rid="dent.REF.grand.2011.476">Grand et al 2011</xref>] were classed according to their functional consequences:</p>
        <list list-type="bullet">
          <list-item>
            <p>Group 1. Pathogenic variants that lead to the retention of the mutated protein in the endoplasmic reticulum</p>
          </list-item>
          <list-item>
            <p>Group 2. Pathogenic variants that generate a functionally defective protein devoid of electric currents and failure of endosomal acidification</p>
          </list-item>
          <list-item>
            <p>Group 3. Pathogenic variants that lead to abnormal subcellular localization of the mature protein</p>
          </list-item>
          <list-item>
            <p>Group 4. Pathogenic variants that generate a protein normally localized at the plasma membrane but with reduced membrane currents</p>
          </list-item>
        </list>
        <table-wrap id="dent.T.clcn5_pathogenic_variants_discuss" orientation="portrait" position="anchor">
          <label>Table 3. </label>
          <caption>
            <p><italic toggle="yes">CLCN5</italic> Pathogenic Variants Discussed in This <italic toggle="yes">GeneReview</italic></p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_dent.T.clcn5_pathogenic_variants_discuss_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Variant Group Classification&#x000a0;<sup>1</sup></th>
                <th id="hd_h_dent.T.clcn5_pathogenic_variants_discuss_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                <th id="hd_h_dent.T.clcn5_pathogenic_variants_discuss_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                <th id="hd_h_dent.T.clcn5_pathogenic_variants_discuss_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_dent.T.clcn5_pathogenic_variants_discuss_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">Group 1</td>
                <td headers="hd_h_dent.T.clcn5_pathogenic_variants_discuss_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">c.731C&#x0003e;T</td>
                <td headers="hd_h_dent.T.clcn5_pathogenic_variants_discuss_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Ser244Leu</td>
                <td headers="hd_h_dent.T.clcn5_pathogenic_variants_discuss_1_1_1_4" rowspan="9" valign="middle" align="left" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_000084.2">NM_000084.2</ext-link>
                  <break/>
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_000075.1">NP_000075.1</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_dent.T.clcn5_pathogenic_variants_discuss_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.815A&#x0003e;G</td>
                <td headers="hd_h_dent.T.clcn5_pathogenic_variants_discuss_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Tyr272Cys</td>
              </tr>
              <tr>
                <td headers="hd_h_dent.T.clcn5_pathogenic_variants_discuss_1_1_1_1" rowspan="3" valign="middle" align="left" scope="row" colspan="1">Group 2</td>
                <td headers="hd_h_dent.T.clcn5_pathogenic_variants_discuss_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">c.674T&#x0003e;C</td>
                <td headers="hd_h_dent.T.clcn5_pathogenic_variants_discuss_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Leu225Pro</td>
              </tr>
              <tr>
                <td headers="hd_h_dent.T.clcn5_pathogenic_variants_discuss_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.1020C&#x0003e;A</td>
                <td headers="hd_h_dent.T.clcn5_pathogenic_variants_discuss_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Asn340Lys</td>
              </tr>
              <tr>
                <td headers="hd_h_dent.T.clcn5_pathogenic_variants_discuss_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.1537G&#x0003e;A</td>
                <td headers="hd_h_dent.T.clcn5_pathogenic_variants_discuss_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Gly513Arg</td>
              </tr>
              <tr>
                <td headers="hd_h_dent.T.clcn5_pathogenic_variants_discuss_1_1_1_1" rowspan="4" valign="middle" align="left" scope="row" colspan="1">Group 3</td>
                <td headers="hd_h_dent.T.clcn5_pathogenic_variants_discuss_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">c.779G&#x0003e;T</td>
                <td headers="hd_h_dent.T.clcn5_pathogenic_variants_discuss_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Gly260Val</td>
              </tr>
              <tr>
                <td headers="hd_h_dent.T.clcn5_pathogenic_variants_discuss_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.834G&#x0003e;C</td>
                <td headers="hd_h_dent.T.clcn5_pathogenic_variants_discuss_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Leu278Phe</td>
              </tr>
              <tr>
                <td headers="hd_h_dent.T.clcn5_pathogenic_variants_discuss_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.1637A&#x0003e;G</td>
                <td headers="hd_h_dent.T.clcn5_pathogenic_variants_discuss_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Lys546Glu</td>
              </tr>
              <tr>
                <td headers="hd_h_dent.T.clcn5_pathogenic_variants_discuss_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.1639T&#x0003e;G</td>
                <td headers="hd_h_dent.T.clcn5_pathogenic_variants_discuss_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Trp547Gly</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
            </fn>
            <fn>
              <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
            </fn>
            <fn id="dent.TF.3.1">
              <label>1. </label>
              <p>
                <xref ref-type="bibr" rid="dent.REF.grand.2011.476">Grand et al [2011]</xref>
              </p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p>For detailed information on <italic toggle="yes">CLCN5</italic> and <italic toggle="yes">OCRL</italic> pathogenic variants, see <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="dent-Tables4-5.pdf" content-type="local-data">Tables 4 and 5</inline-supplementary-material> (pdf).</p>
        <p><bold>Normal gene product.</bold> The clC-5 isoform <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_000075.1">NP_000075.1</ext-link>, encoded by transcript <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_000084.2">NM_000084.2</ext-link>, comprises 746 amino acids. The protein is a voltage-dependent two chloride/proton exchanger. In human kidney, it is expressed in proximal tubular cells, alpha and beta intercalated cells of the cortical collecting tubule, and in the thick ascending limb of Henle&#x02019;s loop. The protein localizes in the intracellular subapical endosomes that are involved in the reabsorption of low molecular-weight proteins filtered through the glomerulus, which are normally completely reabsorbed [<xref ref-type="bibr" rid="dent.REF.smith.2009.f390">Smith et al 2009</xref>]. The function of the protein is to modulate the chloride concentration during proton transport [<xref ref-type="bibr" rid="dent.REF.carrarolacroix.2010.563">Carraro-Lacroix et al 2010</xref>, <xref ref-type="bibr" rid="dent.REF.novarino.2010.1398">Novarino et al 2010</xref>].</p>
        <p><bold>Abnormal gene product.</bold> The abnormal gene products can be either shorter due to the presence of pathogenic truncating variants (nonsense or frameshifts or large DNA rearrangements) or functionally abnormal when an amino acid substitution is present. Defective activity of the protein leads to abnormal protein trafficking and reabsorption. How this causes renal failure and stones is not understood.</p>
        <p>
          <bold>
            <italic toggle="yes">OCRL</italic>
          </bold>
        </p>
        <p><bold>Gene structure.</bold> The gene comprises 5152 nucleotide base pairs and 24 exons, of which 23 are coding. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="dent" object-id="dent.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p><bold>Benign variants.</bold> One small (24-bp) alternatively spliced exon, 18a, encodes an additional eight amino acids and is expressed in neurologic tissues [<xref ref-type="bibr" rid="dent.REF.nussbaum.1997.145">Nussbaum et al 1997</xref>, <xref ref-type="bibr" rid="dent.REF.nussbaum.2001">Nussbaum &#x00026; Suchy 2001</xref>]. It has been hypothesized that brain (but not kidney) can express an exon 8-15 splice variant [<xref ref-type="bibr" rid="dent.REF.shrimpton.2009.27">Shrimpton et al 2009</xref>, <related-object link-type="booklink" source-id="gene" document-id="lowe" document-type="chapter">Lowe Syndrome</related-object>].</p>
        <p><bold>Pathogenic variants.</bold> Forty different pathogenic variants are known to cause Dent disease type 2; however, this number may be over- or underestimated due to the phenotypic overlap of Dent disease type 2 with <related-object link-type="booklink" source-id="gene" document-id="lowe" document-type="chapter">Lowe syndrome</related-object>. The majority (~85%) of pathogenic variants are private; common pathogenic variants (i.e., those found in &#x02265;4 families) are summarized in <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="dent-Tables4-5.pdf" content-type="local-data">Table 4</inline-supplementary-material> (pdf).</p>
        <p>As detailed in <xref ref-type="sec" rid="dent.GenotypePhenotype_Correlations">Genotype-Phenotype Correlations</xref>, <italic toggle="yes">OCRL</italic> frameshift and nonsense variants associated with Dent disease 2 have been mapped to different exons from those causing Lowe syndrome [<xref ref-type="bibr" rid="dent.REF.hichri.2011.379">Hichri et al 2011</xref>]. Note that missense, splicing, and in-frame deletion variants causative of either disease do not map exclusively to specific gene regions. Missense variants associated with Dent disease 2 are most often (but not exclusively) located in exons 9-15, which encode the catalytic phosphatase domain. One deletion of exons 3 and 4 was reported in an affected male [<xref ref-type="bibr" rid="dent.REF.hichri.2011.379">Hichri et al 2011</xref>]. Of the known <italic toggle="yes">OCRL</italic> Dent disease 2-causing variants, 47.5% are truncating, 47.5% non-truncating, and 5% multiexon deletions</p>
        <p><bold>Normal gene product.</bold>
<italic toggle="yes">OCRL</italic> encodes a phosphatidylinositol 4,5-biphosphate 5-phosphatase (OCRL-1), comprising 884 amino acids, which localizes in the trans-Golgi network and the lysosomes. The protein acts as a phosphatase and removes a 5&#x02019; phosphate group from the phosphatidilinositol-4,5-biphosphate, a second messenger that plays a role in the regulation of the vesicular trafficking.</p>
        <p><bold>Abnormal gene product.</bold> The abnormal gene products can be either shorter due to the presence of truncating variants (nonsense or frameshifts or large DNA rearrangements) or functionally abnormal when an amino acid substitution is present.</p>
        <p>The mechanism by which loss of OCRL-1 protein function leads to disease has not yet been elucidated. However, OCRL-1 protein was localized to early endosomes and the <italic toggle="yes">trans</italic> Golgi apparatus, and clathrin coated transport intermediates [<xref ref-type="bibr" rid="dent.REF.choudhury.2005.3467">Choudhury et al 2005</xref>, <xref ref-type="bibr" rid="dent.REF.ghanekar.2005.851">Ghanekar &#x00026; Lowe 2005</xref>]. Depletion of OCRL-1 perturbs trafficking at the TGN/endosome interface, suggesting a role in regulating transport between these compartments.</p>
        <p>The abnormal vesicular trafficking shared with the CLC-5 protein may explain the overlapping clinical features associated with mutation of <italic toggle="yes">CLCN5</italic> and <italic toggle="yes">OCRL</italic>.</p>
      </sec>
      <sec id="dent.References">
        <title>References</title>
        <sec id="dent.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="dent.Literature_Cited.reflist0">
            <ref id="dent.REF.blanchard.2008.1084">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Blanchard</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vargas-Poussou</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peyrard</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mogenet</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baudouin</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boudailliez</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Charbit</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deschesnes</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ezzhair</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Loirat</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Macher</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Niaudet</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Azizi</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Effect of hydrochlorothiazide on urinary calcium excretion in dent disease: an uncontrolled trial.</article-title>
                <source>Am J Kidney Dis.</source>
                <volume>52</volume>
                <fpage>1084</fpage>
                <lpage>95</lpage>
                <pub-id pub-id-type="pmid">18976849</pub-id>
              </element-citation>
            </ref>
            <ref id="dent.REF.b_kenkamp.2009.94">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>B&#x000f6;kenkamp</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>B&#x000f6;ckenhauer</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cheong</surname>
                    <given-names>HI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoppe</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tasic</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Unwin</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ludwig</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Dent-2 disease: a mild variant of Lowe syndrome.</article-title>
                <source>J Pediatr.</source>
                <year>2009</year>
                <volume>155</volume>
                <fpage>94</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">19559295</pub-id>
              </element-citation>
            </ref>
            <ref id="dent.REF.carrarolacroix.2010.563">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Carraro-Lacroix</surname>
                    <given-names>LR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lessa</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bezerra</surname>
                    <given-names>CN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pessoa</surname>
                    <given-names>TD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Souza-Menezes</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morales</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Girardi</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malnic</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <article-title>Role of CFTR and ClC-5 in modulating vacuolar H+-ATPase activity in kidney proximal tubule.</article-title>
                <source>Cell Physiol Biochem</source>
                <year>2010</year>
                <volume>26</volume>
                <fpage>563</fpage>
                <lpage>76</lpage>
                <pub-id pub-id-type="pmid">21063094</pub-id>
              </element-citation>
            </ref>
            <ref id="dent.REF.cebotaru.2005.642">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cebotaru</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaul</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Devuyst</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cai</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Racusen</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guggino</surname>
                    <given-names>WB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guggino</surname>
                    <given-names>SE</given-names>
                  </name>
                </person-group>
                <article-title>High citrate diet delays progression of renal insufficiency in the ClC-5 knockout mouse model of Dent's disease.</article-title>
                <source>Kidney Int</source>
                <year>2005</year>
                <volume>68</volume>
                <fpage>642</fpage>
                <lpage>52</lpage>
                <pub-id pub-id-type="pmid">16014041</pub-id>
              </element-citation>
            </ref>
            <ref id="dent.REF.cho.2008.243">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cho</surname>
                    <given-names>HY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>BH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Choi</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ha</surname>
                    <given-names>IS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Choi</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cheong</surname>
                    <given-names>HI</given-names>
                  </name>
                </person-group>
                <article-title>Renal manifestations of Dent disease and Lowe syndrome.</article-title>
                <source>Pediatr Nephrol.</source>
                <year>2008</year>
                <volume>23</volume>
                <fpage>243</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">18038239</pub-id>
              </element-citation>
            </ref>
            <ref id="dent.REF.choudhury.2005.3467">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Choudhury</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Diao</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eisenberg</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saint-Pol</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Williams</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Konstantakopoulos</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lucocq</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johannes</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rabouille</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Greene</surname>
                    <given-names>LE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lowe</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Lowe syndrome protein OCRL1 interacts with clathrin and regulates protein trafficking between endosomes and the trans-Golgi network.</article-title>
                <source>Mol Biol Cell.</source>
                <year>2005</year>
                <volume>16</volume>
                <fpage>3467</fpage>
                <lpage>79</lpage>
                <pub-id pub-id-type="pmid">15917292</pub-id>
              </element-citation>
            </ref>
            <ref id="dent.REF.claveriemart_n.2011.693">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Claverie-Mart&#x000ed;n</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ramos-Trujillo</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garc&#x000ed;a-Nieto</surname>
                    <given-names>V.</given-names>
                  </name>
                </person-group>
                <article-title>Dent's disease: clinical features and molecular basis.</article-title>
                <source>Pediatr Nephrol</source>
                <year>2011</year>
                <volume>26</volume>
                <fpage>693</fpage>
                <lpage>704</lpage>
                <pub-id pub-id-type="pmid">20936522</pub-id>
              </element-citation>
            </ref>
            <ref id="dent.REF.copelovitch.2007.914">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Copelovitch</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nash</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaplan</surname>
                    <given-names>BS</given-names>
                  </name>
                </person-group>
                <article-title>Hypothesis: Dent disease is an underrecognized cause of focal glomerulosclerosis.</article-title>
                <source>Clin J Am Soc Nephrol</source>
                <year>2007</year>
                <volume>2</volume>
                <fpage>914</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">17702731</pub-id>
              </element-citation>
            </ref>
            <ref id="dent.REF.davey.1982.1330">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Davey</surname>
                    <given-names>PG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gosling</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>B2-Microglobulin instability in pathological urine.</article-title>
                <source>Clin Chem</source>
                <year>1982</year>
                <volume>28</volume>
                <fpage>1330</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">6176371</pub-id>
              </element-citation>
            </ref>
            <ref id="dent.REF.devuyst.2010.28">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Devuyst</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thakker</surname>
                    <given-names>RV</given-names>
                  </name>
                </person-group>
                <article-title>Dent's disease.</article-title>
                <source>Orphanet J Rare Dis.</source>
                <year>2010</year>
                <volume>5</volume>
                <fpage>28</fpage>
                <pub-id pub-id-type="pmid">20946626</pub-id>
              </element-citation>
            </ref>
            <ref id="dent.REF.edvardsson.2013.1923">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Edvardsson</surname>
                    <given-names>VO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldfarb</surname>
                    <given-names>DS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lieske</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beara-Lasic</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anglani</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Milliner</surname>
                    <given-names>DS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palsson</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <article-title>Hereditary causes of kidney stones and chronic kidney disease.</article-title>
                <source>Pediatr Nephrol.</source>
                <year>2013</year>
                <volume>28</volume>
                <fpage>1923</fpage>
                <lpage>42</lpage>
                <pub-id pub-id-type="pmid">23334384</pub-id>
              </element-citation>
            </ref>
            <ref id="dent.REF.frishberg.2009.2369">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Frishberg</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dinour</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Belostotsky</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Becker-Cohen</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rinat</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feinstein</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Navon-Elkan</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ben-Shalom</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <article-title>Dent's disease manifesting as focal glomerulosclerosis: Is it the tip of the iceberg?</article-title>
                <source>Pediatr Nephrol</source>
                <year>2009</year>
                <volume>24</volume>
                <fpage>2369</fpage>
                <lpage>73</lpage>
                <pub-id pub-id-type="pmid">19806368</pub-id>
              </element-citation>
            </ref>
            <ref id="dent.REF.ghanekar.2005.851">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ghanekar</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lowe</surname>
                    <given-names>M.</given-names>
                  </name>
                </person-group>
                <article-title>Signalling for secretion.</article-title>
                <source>Nat Cell Biol.</source>
                <year>2005</year>
                <volume>7</volume>
                <fpage>851</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">16136181</pub-id>
              </element-citation>
            </ref>
            <ref id="dent.REF.grand.2011.476">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Grand</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>L'Hoste</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mordasini</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Defontaine</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keck</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pennaforte</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Genete</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laghmani</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Teulon</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lourdel</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>Heterogeneity in the processing of CLCN5 mutants related to Dent disease.</article-title>
                <source>Hum Mutat.</source>
                <year>2011</year>
                <volume>32</volume>
                <fpage>476</fpage>
                <lpage>83</lpage>
                <pub-id pub-id-type="pmid">21305656</pub-id>
              </element-citation>
            </ref>
            <ref id="dent.REF.hichri.2011.379">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hichri</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rendu</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Monnier</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coutton</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dorseuil</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poussou</surname>
                    <given-names>RV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baujat</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blanchard</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nobili</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ranchin</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Remesy</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salomon</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Satre</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lunardi</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>From Lowe syndrome to Dent disease: correlations between mutations of the OCRL1 gene and clinical and biochemical phenotypes.</article-title>
                <source>Hum Mutat.</source>
                <volume>32</volume>
                <fpage>379</fpage>
                <lpage>88</lpage>
                <pub-id pub-id-type="pmid">21031565</pub-id>
              </element-citation>
            </ref>
            <ref id="dent.REF.hodgin.2008.1320">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hodgin</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Corey</surname>
                    <given-names>HE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaplan</surname>
                    <given-names>BS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D'Agati</surname>
                    <given-names>VD</given-names>
                  </name>
                </person-group>
                <article-title>Dent disease presenting as partial Fanconi syndrome and hypercalciuria.</article-title>
                <source>Kidney Int.</source>
                <year>2008</year>
                <volume>73</volume>
                <fpage>1320</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">18235437</pub-id>
              </element-citation>
            </ref>
            <ref id="dent.REF.hoopes.2004.1615">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hoopes</surname>
                    <given-names>RR</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Raja</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koich</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hueber</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reid</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Knohl</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheinman</surname>
                    <given-names>SJ</given-names>
                  </name>
                </person-group>
                <article-title>Evidence for genetic heterogeneity in Dent's disease.</article-title>
                <source>Kidney Int.</source>
                <year>2004</year>
                <volume>65</volume>
                <fpage>1615</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">15086899</pub-id>
              </element-citation>
            </ref>
            <ref id="dent.REF.hoopes.2005.260">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hoopes</surname>
                    <given-names>RR</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Shrimpton</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Knohl</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hueber</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoppe</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matyus</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simckes</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tasic</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toenshoff</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suchy</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nussbaum</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheinman</surname>
                    <given-names>SJ</given-names>
                  </name>
                </person-group>
                <article-title>Dent disease with mutations in OCRL1.</article-title>
                <source>Am J Hum Genet</source>
                <year>2005</year>
                <volume>76</volume>
                <fpage>260</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">15627218</pub-id>
              </element-citation>
            </ref>
            <ref id="dent.REF.kantarci.2007.957">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kantarci</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Gazali</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hill</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Donnai</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Black</surname>
                    <given-names>GC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bieth</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chassaing</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lacombe</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Devriendt</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Teebi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Loscertales</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robson</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>MacLaughlin</surname>
                    <given-names>DT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Noonan</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Russell</surname>
                    <given-names>MK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walsh</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Donahoe</surname>
                    <given-names>PK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pober</surname>
                    <given-names>BR</given-names>
                  </name>
                </person-group>
                <article-title>Mutations in LRP2, which encodes the multiligand receptor megalin, cause Donnai-Barrow and facio-oculo-acoustico-renal syndromes.</article-title>
                <source>Nat Genet.</source>
                <year>2007</year>
                <volume>39</volume>
                <fpage>957</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">17632512</pub-id>
              </element-citation>
            </ref>
            <ref id="dent.REF.lloyd.1997.967">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lloyd</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pearce</surname>
                    <given-names>SHS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guenther</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kawaguchi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Igarashi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jentsch</surname>
                    <given-names>TJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thakker</surname>
                    <given-names>RV</given-names>
                  </name>
                </person-group>
                <article-title>Idiopathic low molecular weight proteinuria associated with hypercalciuric nephroclacinosis in Japanese children is due to mutations of the renal chloride channel (CLCN5).</article-title>
                <source>J Clin Invest</source>
                <year>1997</year>
                <volume>99</volume>
                <fpage>967</fpage>
                <lpage>74</lpage>
                <pub-id pub-id-type="pmid">9062355</pub-id>
              </element-citation>
            </ref>
            <ref id="dent.REF.lozanovski.2011.280">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lozanovski</surname>
                    <given-names>VJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ristoska-Bojkovska</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Korneti</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gucev</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tasic</surname>
                    <given-names>V</given-names>
                  </name>
                </person-group>
                <article-title>OCRL1 mutation in a boy with Dent disease, mild mental retardation, but without cataracts.</article-title>
                <source>World J Pediatr.</source>
                <year>2011</year>
                <volume>7</volume>
                <fpage>280</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">21822997</pub-id>
              </element-citation>
            </ref>
            <ref id="dent.REF.ludwig.2014">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ludwig</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levtchenko</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>B&#x000f6;kenkamp</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Clinical utility gene card for: Dent disease (Dent-1 and Dent-2)</article-title>
                <source>Eur J Hum Genet.</source>
                <year>2014</year>
                <volume>22</volume>
                <issue>11</issue>
                <pub-id pub-id-type="pmid">24619144</pub-id>
              </element-citation>
            </ref>
            <ref id="dent.REF.matos.1997.252">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Matos</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Melle</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boulat</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Markert</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bachmann</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guignard</surname>
                    <given-names>JP</given-names>
                  </name>
                </person-group>
                <article-title>Urinary phosphate/creatinine, calcium/creatinine, and magnesium/creatinine ratios in a healthy pediatric population.</article-title>
                <source>J Pediatr.</source>
                <year>1997</year>
                <volume>131</volume>
                <fpage>252</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">9290612</pub-id>
              </element-citation>
            </ref>
            <ref id="dent.REF.novarino.2010.1398">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Novarino</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weinert</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rickheit</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jentsch</surname>
                    <given-names>TJ</given-names>
                  </name>
                </person-group>
                <article-title>Endosomal chloride-proton exchange rather than chloride conductance is crucial for renal endocytosis.</article-title>
                <source>Science</source>
                <year>2010</year>
                <volume>328</volume>
                <fpage>1398</fpage>
                <lpage>401</lpage>
                <pub-id pub-id-type="pmid">20430975</pub-id>
              </element-citation>
            </ref>
            <ref id="dent.REF.nussbaum.1997.145">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nussbaum</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Orrison</surname>
                    <given-names>BM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>J&#x000e4;nne</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Charnas</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chinault</surname>
                    <given-names>AC</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Physical mapping and genomic structure of the Lowe syndrome gene OCRL1.</article-title>
                <source>Hum Genet.</source>
                <volume>99</volume>
                <fpage>145</fpage>
                <lpage>50</lpage>
                <pub-id pub-id-type="pmid">9048911</pub-id>
              </element-citation>
            </ref>
            <ref id="dent.REF.nussbaum.2001">
              <mixed-citation publication-type="book">Nussbaum RL, Suchy SF. The oculocerebrorenal syndrome of Lowe (Lowe syndrome). In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. <italic toggle="yes">The Metabolic and Molecular Bases of Inherited Disease</italic>. 8 ed. Chap 252. New York, NY: McGraw-Hill; 2001:6257-66.</mixed-citation>
            </ref>
            <ref id="dent.REF.pober.2009.76">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pober</surname>
                    <given-names>BR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Longoni</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Noonan</surname>
                    <given-names>KM</given-names>
                  </name>
                </person-group>
                <article-title>A review of Donnai-Barrow and facio-oculo-acoustico-renal (DB/FOAR) syndrome: clinical features and differential diagnosis.</article-title>
                <source>Birth Defects Res A Clin Mol Teratol.</source>
                <year>2009</year>
                <volume>85</volume>
                <fpage>76</fpage>
                <lpage>81</lpage>
                <pub-id pub-id-type="pmid">19089858</pub-id>
              </element-citation>
            </ref>
            <ref id="dent.REF.raja.2002.2938">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Raja</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schurman</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D'Mello</surname>
                    <given-names>R G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blowey</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goodyer</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Why</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ploutz-Snyder</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Asplin</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheinman</surname>
                    <given-names>SJ</given-names>
                  </name>
                </person-group>
                <article-title>Responsiveness of hypercalciuria to thiazide in Dent's disease.</article-title>
                <source>J Am Soc Nephrol</source>
                <year>2002</year>
                <volume>13</volume>
                <fpage>2938</fpage>
                <lpage>44</lpage>
                <pub-id pub-id-type="pmid">12444212</pub-id>
              </element-citation>
            </ref>
            <ref id="dent.REF.scheinman.1998.3">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Scheinman</surname>
                    <given-names>SJ</given-names>
                  </name>
                </person-group>
                <article-title>X-linked hypercalciuric nephrolithiasis: clinical syndromes and chloride channel mutations.</article-title>
                <source>Kidney Int</source>
                <year>1998</year>
                <volume>53</volume>
                <fpage>3</fpage>
                <lpage>17</lpage>
                <pub-id pub-id-type="pmid">9452994</pub-id>
              </element-citation>
            </ref>
            <ref id="dent.REF.scheinman.2000.232">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Scheinman</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cox</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lloyd</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pearce</surname>
                    <given-names>SH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salenger</surname>
                    <given-names>PV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoopes</surname>
                    <given-names>RR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bushinsky</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wrong</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Asplin</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Langman</surname>
                    <given-names>CB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Norden</surname>
                    <given-names>AG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thakker</surname>
                    <given-names>RV</given-names>
                  </name>
                </person-group>
                <article-title>Isolated hypercalciuria with mutation in CLCN5: relevance to idiopathic hypercalciuria.</article-title>
                <source>Kidney Int.</source>
                <year>2000</year>
                <volume>57</volume>
                <fpage>232</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">10620204</pub-id>
              </element-citation>
            </ref>
            <ref id="dent.REF.shefferbabila.2008.279">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sheffer-Babila</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chandra</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Speiser</surname>
                    <given-names>PW</given-names>
                  </name>
                </person-group>
                <article-title>Growth hormone improves growth rate and preserves renal function in Dent disease.</article-title>
                <source>J Pediatr Endocrinol Metab.</source>
                <year>2008</year>
                <volume>21</volume>
                <fpage>279</fpage>
                <lpage>86</lpage>
                <pub-id pub-id-type="pmid">18540256</pub-id>
              </element-citation>
            </ref>
            <ref id="dent.REF.shrimpton.2009.27">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shrimpton</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoopes</surname>
                    <given-names>RR</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Knohl</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hueber</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reed</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Christie</surname>
                    <given-names>PT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Igarashi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lehman</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>White</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Milford</surname>
                    <given-names>DV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sanchez</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Unwin</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wrong</surname>
                    <given-names>OM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thakker</surname>
                    <given-names>RV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheinman</surname>
                    <given-names>SJ</given-names>
                  </name>
                </person-group>
                <article-title>OCRL1 mutations in Dent 2 patients suggest a mechanism for phenotypic variability.</article-title>
                <source>Nephron Physiol.</source>
                <year>2009</year>
                <volume>112</volume>
                <fpage>27</fpage>
                <lpage>36</lpage>
                <pub-id pub-id-type="pmid">19390221</pub-id>
              </element-citation>
            </ref>
            <ref id="dent.REF.smith.2009.f390">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reed</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Loh</surname>
                    <given-names>NY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thakker</surname>
                    <given-names>RV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lippiat</surname>
                    <given-names>JD</given-names>
                  </name>
                </person-group>
                <article-title>Characterization of Dent's disease mutations of CLC-5 reveals a correlation between functional and cell biological consequences and protein structure.</article-title>
                <source>Am J Physiol Renal Physiol</source>
                <year>2009</year>
                <volume>296</volume>
                <fpage>F390</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">19019917</pub-id>
              </element-citation>
            </ref>
            <ref id="dent.REF.tasic.2011.557">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tasic</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lozanovski</surname>
                    <given-names>VJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Korneti</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ristoska-Bojkovska</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sabolic-Avramovska</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gucev</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ludwig</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Clinical and laboratory features of Macedonian children with OCRL mutations.</article-title>
                <source>Pediatr Nephrol.</source>
                <year>2011</year>
                <volume>26</volume>
                <fpage>557</fpage>
                <lpage>62</lpage>
                <pub-id pub-id-type="pmid">21249396</pub-id>
              </element-citation>
            </ref>
            <ref id="dent.REF.tosetto.2009.1967">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tosetto</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Addis</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Caridi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meloni</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Emma</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vergine</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stringini</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Papalia</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barbano</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ghiggeri</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruggeri</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miglietti</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <article-title>D Angelo A, Melis MA, Anglani F. Locus heterogeneity of Dent's disease: OCRL1 and TMEM27 genes in patients with no CLCN5 mutations.</article-title>
                <source>Pediatr Nephrol</source>
                <year>2009</year>
                <volume>24</volume>
                <fpage>1967</fpage>
                <lpage>73</lpage>
                <pub-id pub-id-type="pmid">19582483</pub-id>
              </element-citation>
            </ref>
            <ref id="dent.REF.utsch.2006.942.e1">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Utsch</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>B&#x000f6;kenkamp</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benz</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Besbas</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D&#x000f6;tsch</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Franke</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fr&#x000fc;nd</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gok</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoppe</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karle</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuwertz-Br&#x000f6;king</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laube</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neb</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nuutinen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ozaltin</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rascher</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ring</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tasic</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Wijk</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ludwig</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Novel OCRL1 mutations in patients with the phenotype of Dent disease.</article-title>
                <source>Am J Kidney Dis.</source>
                <year>2006</year>
                <volume>48</volume>
                <fpage>942.e1</fpage>
                <lpage>14</lpage>
                <pub-id pub-id-type="pmid">17162149</pub-id>
              </element-citation>
            </ref>
            <ref id="dent.REF.valina.2013.377">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Valina</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Larsen</surname>
                    <given-names>CP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kanosky</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suchy</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nield</surname>
                    <given-names>LS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Onder</surname>
                    <given-names>AM</given-names>
                  </name>
                </person-group>
                <article-title>A novel CLCN5 mutation in a boy with asymptomatic proteinuria and focal global glomerulosclerosis.</article-title>
                <source>Clin Nephrol.</source>
                <year>2013</year>
                <volume>80</volume>
                <fpage>377</fpage>
                <lpage>84</lpage>
                <pub-id pub-id-type="pmid">22735364</pub-id>
              </element-citation>
            </ref>
            <ref id="dent.REF.wrong.1994.473">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wrong</surname>
                    <given-names>OM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Norden</surname>
                    <given-names>AG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feest</surname>
                    <given-names>TG</given-names>
                  </name>
                </person-group>
                <article-title>Dent's disease; a familial proximal renal tubular syndrome with low-molecular-weight proteinuria, hypercalciuria, nephrocalcinosis, metabolic bone disease, progressive renal failure and a marked male predominance.</article-title>
                <source>QJM</source>
                <year>1994</year>
                <volume>87</volume>
                <fpage>473</fpage>
                <lpage>93</lpage>
                <pub-id pub-id-type="pmid">7922301</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="dent.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="dent.Author_Notes">
          <title>Author Notes</title>
          <p>
            <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.rarekidneystones.org/">Rare Kidney Stone Consortium</ext-link>
          </p>
          <p>
            <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://rarediseasesnetwork.epi.usf.edu/RKSC/">Rare Diseases Clinical Research Network - Rare Kidney Stone Consortium</ext-link>
          </p>
          <p>The Rare Kidney Stone Consortium is a resource for patients, their families, and physicians. The center facilitates collaborative research to provide better understanding of Dent Disease and other rare types of kidney stones. For more information about Dent disease, please e-mail the Rare Kidney Stone Consortium at rarekidneystones@mayo.edu or call 800-270-4637.</p>
        </sec>
        <sec id="dent.Author_History">
          <title>Author History</title>
          <p>Lada Beara-Lasic, MD (2012-present)Andrea Cogal, BS (2014-present) Peter Harris, PhD (2014-present) Katharina Hopp, PhD (2014-present)John C Lieske, MD (2012-present)Kari Mattison (2014-present) Dawn S Milliner, MD (2012-present)Sandro Rossetti, MD; Mayo Clinic (2012-2014)</p>
        </sec>
        <sec id="dent.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>25 September 2014 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>9 August 2012 (me) Review posted live</p>
            </list-item>
            <list-item>
              <p>1 March 2012 (jcl) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
